Reference Type:  Journal Article
Record Number: 1084
Author: Toledo, J. B., Da, X., Bhatt, P., Wolk, D. A., Arnold, S. E., Shaw, L. M., Trojanowski, J. Q. and Davatzikos, C.
Year: 2013
Title: Relationship between Plasma Analytes and SPARE-AD Defined Brain Atrophy Patterns in ADNI
Journal: PLoS ONE
Volume: 8
Issue: 2
Short Title: Relationship between Plasma Analytes and SPARE-AD Defined Brain Atrophy Patterns in ADNI
ISSN: 19326203 (ISSN)
DOI: 10.1371/journal.pone.0055531
Keywords: amyloid beta protein[1-42]
apolipoprotein E4
biological marker
chromogranin A
hydrocortisone
insulin
macrophage inflammatory protein 1alpha
somatomedin binding protein 2
tau protein
aged
Alzheimer disease
article
blood analysis
brain atrophy
cell transport
cerebrospinal fluid analysis
cohort analysis
computer program
controlled study
correlation analysis
disease association
female
human
hydrocortisone blood level
inflammatory cell
information processing
major clinical study
male
mild cognitive impairment
named inventories, questionnaires and rating scales
nuclear magnetic resonance imaging
response time
Spatial Pattern of Abnormality for Recognition of Early Alzheimer disease
stress
task performance
Amyloid beta-Peptides
Biological Markers
Cohort Studies
Humans
Insulin-Like Growth Factor Binding Protein 2
Macrophage Migration-Inhibitory Factors
Magnetic Resonance Imaging
tau Proteins
Abstract: Different inflammatory and metabolic pathways have been associated with Alzheimeŕs disease (AD). However, only recently multi-analyte panels to study a large number of molecules in well characterized cohorts have been made available. These panels could help identify molecules that point to the affected pathways. We studied the relationship between a panel of plasma biomarkers (Human DiscoveryMAP®) and presence of AD-like brain atrophy patterns defined by a previously published index (SPARE-AD) at baseline in subjects of the ADNI cohort. 818 subjects had MRI-derived SPARE-AD scores, of these subjects 69% had plasma biomarkers and 51% had CSF tau and Aβ measurements. Significant analyte-SPARE-AD and analytes correlations were studied in adjusted models. Plasma cortisol and chromogranin A showed a significant association that did not remain significant in the CSF signature adjusted model. Plasma macrophage inhibitory protein-1α and insulin-like growth factor binding protein 2 showed a significant association with brain atrophy in the adjusted model. Cortisol levels showed an inverse association with tests measuring processing speed. Our results indicate that stress and insulin responses and cytokines associated with recruitment of inflammatory cells in MCI-AD are associated with its characteristic AD-like brain atrophy pattern and correlate with clinical changes or CSF biomarkers. © 2013 Toledo et al.
Notes: Cited By (since 1996):5
Export Date: 28 May 2014
Source: Scopus
Art. No.: e55531
PubMed ID: 23408997
Language of Original Document: English
Correspondence Address: Davatzikos, C.; Section of Biomedical Image Analysis, Department of Radiology, University of Pennsylvania, Philadelphia, PA, United States; email: christos@rad.upenn.edu
Chemicals/CAS: hydrocortisone, 50-23-7; insulin, 9004-10-8; macrophage inflammatory protein 1alpha, 155075-84-6; Amyloid beta-Peptides; Biological Markers; Chromogranin A; Hydrocortisone, 50-23-7; Insulin-Like Growth Factor Binding Protein 2; Macrophage Migration-Inhibitory Factors; tau Proteins
Tradenames: Human DiscoveryMAP; Rules Based Medicine
References: Hyman, B.T., Trojanowski, J.Q., Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease (1997) J Neuropathol Exp Neurol, 56, pp. 1095-1097; Khachaturian, Z.S., Diagnosis of Alzheimer's disease (1985) Arch Neurol, 42, pp. 1097-1105; Braak, H., Braak, E., Neuropathological stageing of Alzheimer-related changes (1991) Acta Neuropathol, 82, pp. 239-259; Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M., Crain, B.J., The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease (1991) Neurology, 41, pp. 479-486; Gomez-Isla, T., Price, J.L., McKeel Jr., D.W., Morris, J.C., Growdon, J.H., Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease (1996) J Neurosci, 16, pp. 4491-4500; Scheff, S.W., Price, D.A., Synapse loss in the temporal lobe in Alzheimer's disease (1993) Ann Neurol, 33, pp. 190-199; Scheff, S.W., Price, D.A., Schmitt, F.A., DeKosky, S.T., Mufson, E.J., Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment (2007) Neurology, 68, pp. 1501-1508; Selkoe, D.J., Alzheimer's disease is a synaptic failure (2002) Science, 298, pp. 789-791; Knobloch, M., Mansuy, I.M., Dendritic spine loss and synaptic alterations in Alzheimer's disease (2008) Mol Neurobiol, 37, pp. 73-82; Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Inflammation and Alzheimer's disease (2000) Neurobiol Aging, 21, pp. 383-421; Glass, C.K., Saijo, K., Winner, B., Marchetto, M.C., Gage, F.H., Mechanisms underlying inflammation in neurodegeneration (2010) Cell, 140, pp. 918-934; McGeer, P.L., Kawamata, T., Walker, D.G., Akiyama, H., Tooyama, I., Microglia in degenerative neurological disease (1993) Glia, 7, pp. 84-92; Mancardi, G.L., Liwnicz, B.H., Mandybur, T.I., Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type (1983) Acta Neuropathol, 61, pp. 76-80; Acosta-Baena, N., Sepulveda-Falla, D., Lopera-Gomez, C.M., Jaramillo-Elorza, M.C., Moreno, S., Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study (2011) Lancet Neurol, 10, pp. 213-220; Jack Jr., C.R., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade (2010) Lancet Neurol, 9, pp. 119-128; Gatz, M., Reynolds, C.A., Fratiglioni, L., Johansson, B., Mortimer, J.A., Role of Genes and Environments for Explaining Alzheimer Disease (2006) Arch Gen Psychiatry, 63, pp. 168-174; Reitz, C., Brayne, C., Mayeux, R., Epidemiology of Alzheimer disease (2011) Nat Rev Neurol, 7, pp. 137-152; Barnes, D.E., Yaffe, K., The projected effect of risk factor reduction on Alzheimer's disease prevalence (2011) Lancet Neurol, 10, pp. 819-828; Kalaria, R.N., Akinyemi, R., Ihara, M., Does vascular pathology contribute to Alzheimer changes? (2012) J Neurol Sci.; Kling, M.A., Trojanowski, J.Q., Wolk, D.A., Lee, V.M., Arnold, S.E., Vascular disease and dementias: Paradigm shifts to drive research in new directions (2012) Alzheimers Dement; Toledo, J.B., Toledo, E., Weiner, M.W., Jack Jr., C.R., Jagust, W., Cardiovascular risk factors, cortisol, and amyloid-beta deposition in Alzheimer's Disease Neuroimaging Initiative (2012) Alzheimers Dement, 8, pp. 483-489; Wang, Y., Fan, Y., Bhatt, P., Davatzikos, C., High-dimensional pattern regression using machine learning: from medical images to continuous clinical variables (2010) Neuroimage, 50, pp. 1519-1535; Filipovych, R., Davatzikos, C., Semi-supervised pattern classification of medical images: application to mild cognitive impairment (MCI) (2011) NeuroImage, 55, pp. 1109-1119; Misra, C., Fan, Y., Davatzikos, C., Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI (2009) NeuroImage, 44, pp. 1415-1422; Davatzikos, C., Bhatt, P., Shaw, L.M., Batmanghelich, K.N., Trojanowski, J.Q., Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification (2011) Neurobiol Aging, 32, pp. 2319-2327; Davatzikos, C., Xu, F., An, Y., Fan, Y., Resnick, S.M., Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index (2009) Brain, 132, pp. 2026-2035; Jack Jr., C.R., Bernstein, M.A., Fox, N.C., Thompson, P., Alexander, G., The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods (2008) J Magn Reson Imaging, 27, pp. 685-691; Jagust, W.J., Bandy, D., Chen, K., Foster, N.L., Landau, S.M., The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core (2010) Alzheimer's and Dementia, 6, pp. 221-229; Shaw, L.M., Vanderstichele, H., Knapik-Czajka, M., Clark, C., Aisen, P., Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects (2009) Annals of Neurology, 65, pp. 403-413; Petersen, R.C.P.M.D., Aisen, P.S.M., Beckett, L.A.P., Donohue, M.C.P., Gamst, A.C.P., Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization (2010) Neurology, 74, pp. 201-209; Friedman, B., Heisel, M.J., Delavan, R.L., Psychometric properties of the 15-item geriatric depression scale in functionally impaired, cognitively intact, community-dwelling elderly primary care patients (2005) J Am Geriatr Soc, 53, pp. 1570-1576; Petersen, R.C., Aisen, P.S., Beckett, L.A., Donohue, M.C., Gamst, A.C., Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization (2010) Neurology, 74, pp. 201-209; Toledo, J.B., Vanderstichele, H., Figurski, M., Aisen, P.S., Petersen, R.C., Factors affecting Abeta plasma levels and their utility as biomarkers in ADNI (2011) Acta Neuropathol, 122, pp. 401-413; Goldszal, A.F., Davatzikos, C., Pham, D.L., Yan, M.X., Bryan, R.N., An image-processing system for qualitative and quantitative volumetric analysis of brain images (1998) J Comput Assist Tomogr, 22, pp. 827-837; Kabani, N., MacDonald, D., Holmes, C.J., Evans, A., A 3D atlas of the human brain (1998) NeuroImage, 7, pp. S717; Fan, Y., Batmanghelich, N., Clark, C.M., Davatzikos, C., Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline (2008) NeuroImage, 39, pp. 1731-1743; Fan, Y., Shen, D., Gur, R.C., Gur, R.E., Davatzikos, C., COMPARE: classification of morphological patterns using adaptive regional elements (2007) IEEE Trans Med Imaging, 26, pp. 93-105; Weisberg, S., (2005) Applied Linear Regression, , 3rd edition: Wiley; Strimmer, K., A unified approach to false discovery rate estimation (2008) BMC Bioinformatics, 9, p. 303; Ryan, J.R., Paolo, A.M., A screening procedure for estimating premorbid intelligence in the elderly (1992) The Clinical Neuropsychologist, 6, pp. 53-62; Alexander, G., Furey, M., Grady, C., Pietrini, P., Brady, D., Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis (1997) Am J Psychiatry, 154, pp. 165-172; Green, K.N., Billings, L.M., Roozendaal, B., McGaugh, J.L., LaFerla, F.M., Glucocorticoids Increase Amyloid-β and Tau Pathology in a Mouse Model of Alzheimer's Disease (2006) The Journal of Neuroscience, 26, pp. 9047-9056; Kang, J.E., Cirrito, J.R., Dong, H., Csernansky, J.G., Holtzman, D.M., Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity (2007) Proc Natl Acad Sci U S A, 104, pp. 10673-10678; Sotiropoulos, I., Catania, C., Pinto, L.G., Silva, R., Pollerberg, G.E., Stress acts cumulatively to precipitate Alzheimer's disease-like tau pathology and cognitive deficits (2011) J Neurosci, 31, pp. 7840-7847; Sotiropoulos, I., Catania, C., Riedemann, T., Fry, J.P., Breen, K.C., Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau (2008) J Neurochem, 107, pp. 385-397; Rissman, R.A., Lee, K.F., Vale, W., Sawchenko, P.E., Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation (2007) J Neurosci, 27, pp. 6552-6562; Carroll, J.C., Iba, M., Bangasser, D.A., Valentino, R.J., James, M.J., Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy (2011) J Neurosci, 31, pp. 14436-14449; Yau, J.L., Noble, J., Seckl, J.R., 11beta-hydroxysteroid dehydrogenase type 1 deficiency prevents memory deficits with aging by switching from glucocorticoid receptor to mineralocorticoid receptor-mediated cognitive control (2011) J Neurosci, 31, pp. 4188-4193; Budas, G., Coughlan, C.M., Seckl, J.R., Breen, K.C., The effect of corticosteroids on amyloid beta precursor protein/amyloid precursor-like protein expression and processing in vivo (1999) Neurosci Lett, 276, pp. 61-64; Haller, J., Mikics, E., Makara, G.B., The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings (2008) Front Neuroendocrinol, 29, pp. 273-291; Yamamoto, K.R., Steroid receptor regulated transcription of specific genes and gene networks (1985) Annu Rev Genet, 19, pp. 209-252; Liston, C., Gan, W.-B., Glucocorticoids are critical regulators of dendritic spine development and plasticity in vivo (2011) Proceedings of the National Academy of Sciences, 108, pp. 16074-16079; Wellman, C.L., Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration (2001) J Neurobiol, 49, pp. 245-253; Stranahan, A.M., Arumugam, T.V., Cutler, R.G., Lee, K., Egan, J.M., Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons (2008) Nat Neurosci, 11, pp. 309-317; Joels, M., Karst, H., Krugers, H.J., Lucassen, P.J., Chronic stress: implications for neuronal morphology, function and neurogenesis (2007) Front Neuroendocrinol, 28, pp. 72-96; Popoli, M., Yan, Z., McEwen, B.S., Sanacora, G., The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission (2012) Nat Rev Neurosci, 13, pp. 22-37; Cerqueira, J.J., Mailliet, F., Almeida, O.F., Jay, T.M., Sousa, N., The prefrontal cortex as a key target of the maladaptive response to stress (2007) J Neurosci, 27, pp. 2781-2787; Goldwater, D.S., Pavlides, C., Hunter, R.G., Bloss, E.B., Hof, P.R., Structural and functional alterations to rat medial prefrontal cortex following chronic restraint stress and recovery (2009) Neuroscience, 164, pp. 798-808; Young, A.H., Sahakian, B.J., Robbins, T.W., Cowen, P.J., The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers (1999) Psychopharmacology (Berl), 145, pp. 260-266; Lupien, S., Lecours, A.R., Lussier, I., Schwartz, G., Nair, N.P., Basal cortisol levels and cognitive deficits in human aging (1994) J Neurosci, 14, pp. 2893-2903; Huang, C.-W., Lui, C.-C., Chang, W.-N., Lu, C.-H., Wang, Y.-L., Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer's disease (2009) Journal of Clinical Neuroscience, 16, pp. 1283-1286; Cerqueira, J.J., Pego, J.M., Taipa, R., Bessa, J.M., Almeida, O.F., Morphological correlates of corticosteroid-induced changes in prefrontal cortex-dependent behaviors (2005) J Neurosci, 25, pp. 7792-7800; Brown, S.M., Henning, S., Wellman, C.L., Mild, short-term stress alters dendritic morphology in rat medial prefrontal cortex (2005) Cereb Cortex, 15, pp. 1714-1722; Gold, S.M., Dziobek, I., Rogers, K., Bayoumy, A., McHugh, P.F., Hypertension and hypothalamo-pituitary-adrenal axis hyperactivity affect frontal lobe integrity (2005) J Clin Endocrinol Metab, 90, pp. 3262-3267; Quirk, G.J., Russo, G.K., Barron, J.L., Lebron, K., The role of ventromedial prefrontal cortex in the recovery of extinguished fear (2000) J Neurosci, 20, pp. 6225-6231; Hoefer, M., Allison, S.C., Schauer, G.F., Neuhaus, J.M., Hall, J., Fear conditioning in frontotemporal lobar degeneration and Alzheimer's disease (2008) Brain, 131, pp. 1646-1657; Gourley, S.L., Kedves, A.T., Olausson, P., Taylor, J.R., A history of corticosterone exposure regulates fear extinction and cortical NR2B, GluR2/3, and BDNF (2009) Neuropsychopharmacology, 34, pp. 707-716; Ansell, E.B., Rando, K., Tuit, K., Guarnaccia, J., Sinha, R., Cumulative adversity and smaller gray matter volume in medial prefrontal, anterior cingulate, and insula regions (2012) Biol Psychiatry, 72, pp. 57-64; Lindauer, R.J., Vlieger, E.J., Jalink, M., Olff, M., Carlier, I.V., Smaller hippocampal volume in Dutch police officers with posttraumatic stress disorder (2004) Biol Psychiatry, 56, pp. 356-363; Toledo, J.B., Brettschneider, J., Grossman, M., Arnold, S.E., Hu, W.T., CSF biomarkers cutoffs: the importance of coincident neuropathological diseases (2012) Acta Neuropathol; Jellinger, K.A., Attems, J., Prevalence of dementia disorders in the oldest-old: an autopsy study (2010) Acta Neuropathol, 119, pp. 421-433; Naj, A.C., Jun, G., Beecham, G.W., Wang, L.S., Vardarajan, B.N., Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease (2011) Nat Genet, 43, pp. 436-441; Reiman, E.M., Webster, J.A., Myers, A.J., Hardy, J., Dunckley, T., GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers (2007) Neuron, 54, pp. 713-720; Hollingworth, P., Harold, D., Sims, R., Gerrish, A., Lambert, J.C., Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease (2011) Nat Genet, 43, pp. 429-435; Kauwe, J.S.K., Cruchaga, C., Karch, C.M., Sadler, B., Lee, M., Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease (2011) PLoS ONE, 6, pp. e15918; Thambisetty, M., An, Y., Kinsey, A., Koka, D., Saleem, M., Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment (2012) NeuroImage, 59, pp. 212-217; Prinz, M., Priller, J., Sisodia, S.S., Ransohoff, R.M., Heterogeneity of CNS myeloid cells and their roles in neurodegeneration (2011) Nat Neurosci, 14, pp. 1227-1235; Man, S.M., Ma, Y.R., Shang, D.S., Zhao, W.D., Li, B., Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease (2007) Neurobiol Aging, 28, pp. 485-496; Li, M., Shang, D.S., Zhao, W.D., Tian, L., Li, B., Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier (2009) J Immunol, 182, pp. 5778-5788; Zozulya, A.L., Reinke, E., Baiu, D.C., Karman, J., Sandor, M., Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases (2007) J Immunol, 178, pp. 520-529; Hoeflich, A., Nedbal, S., Blum, W.F., Erhard, M., Lahm, H., Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2 (2001) Endocrinology, 142, pp. 1889-1898; Kiepe, D., Ulinski, T., Powell, D.R., Durham, S.K., Mehls, O., Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes (2002) Kidney Int, 62, pp. 1591-1600; Shen, X., Xi, G., Maile, L.A., Wai, C., Rosen, C.J., Insulin-like growth factor binding protein-2 functions coordinately with receptor protein tyrosine phosphatase beta and the IGF-I receptor to regulate IGF-I-stimulated signaling (2012) Mol Cell Biol; de la Monte, S.M., Wands, J.R., Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease (2005) J Alzheimers Dis, 7, pp. 45-61; Schubert, M., Brazil, D.P., Burks, D.J., Kushner, J.A., Ye, J., Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation (2003) J Neurosci, 23, pp. 7084-7092; Talbot, K., Wang, H.Y., Kazi, H., Han, L.Y., Bakshi, K.P., Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline (2012) J Clin Invest, 122, pp. 1316-1338; Hooper, C., Fry, V.A., Sevastou, I.G., Pocock, J.M., Scavenger receptor control of chromogranin A-induced microglial stress and neurotoxic cascades (2009) FEBS Lett, 583, pp. 3461-3466; Perrin, R.J., Craig-Schapiro, R., Malone, J.P., Shah, A.R., Gilmore, P., Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease (2011) PLoS ONE, 6, pp. e16032; Soares, H.D., Chen, Y., Sabbagh, M., Roher, A., Schrijvers, E., Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels (2009) Ann N Y Acad Sci, 1180, pp. 56-67; Schrijvers, E.M.C., Koudstaal, P.J., Hofman, A., Breteler, M.M.B., Plasma Clusterin and the Risk of Alzheimer Disease (2011) JAMA: The Journal of the American Medical Association, 305, pp. 1322-1326; O'Bryant, S.E., Xiao, G., Barber, R., Huebinger, R., Wilhelmsen, K., A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI (2011) PLoS ONE, 6, pp. e28092; Hu, W.T., Holtzman, D.M., Fagan, A.M., Shaw, L.M., Perrin, R., Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease (2012) Neurology, 79, pp. 897-905; Soares, H.D., Potter, W.Z., Pickering, E., Kuhn, M., Immermann, F.W., Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease (2012) Arch Neurol, pp. 1-8; O'Bryant, S.E., Xiao, G., Barber, R., Reisch, J., Doody, R., A serum protein-based algorithm for the detection of Alzheimer disease (2010) Arch Neurol, 67, pp. 1077-1081; Britschgi, M., Rufibach, K., Huang, S.L., Clark, C.M., Kaye, J.A., Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome (2011) Mol Cell Proteomics, 10, pp. M111. , 008862; Bian, H., Van Swieten, J.C., Leight, S., Massimo, L., Wood, E., CSF biomarkers in frontotemporal lobar degeneration with known pathology (2008) Neurology, 70, pp. 1827-1835; Fagan, A.M., Roe, C.M., Xiong, C., Mintun, M.A., Morris, J.C., Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults (2007) Arch Neurol, 64, pp. 343-349; Li, G., Sokal, I., Quinn, J.F., Leverenz, J.B., Brodey, M., CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study (2007) Neurology, 69, pp. 631-639; Kester, M.I., Scheffer, P.G., Koel-Simmelink, M.J., Twaalfhoven, H., Verwey, N.A., Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers (2011) Neurobiol Aging; Ikonomovic, M.D., Klunk, W.E., Abrahamson, E.E., Mathis, C.A., Price, J.C., Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease (2008) Brain, 131, pp. 1630-1645; Kadir, A., Marutle, A., Gonzalez, D., Schöll, M., Almkvist, O., Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease (2011) Brain, 134, pp. 301-317; Buchhave, P., Blennow, K., Zetterberg, H., Stomrud, E., Londos, E., Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease (2009) PLoS ONE, 4, pp. e6294; Davatzikos, C., Resnick, S.M., Wu, X., Parmpi, P., Clark, C.M., Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI (2008) NeuroImage, 41, pp. 1220-1227
URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-84873690493&partnerID=40&md5=3b2f83a724146f2a0b6ca968a53701cb
Author Address: Department of Pathology and Laboratory Medicine, Institute on Aging, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, United States
Section of Biomedical Image Analysis, Department of Radiology, University of Pennsylvania, Philadelphia, PA, United States
Penn Memory Center, University of Pennsylvania, Philadelphia, PA, United States


